Get the Stockscreener App
0.9594
2.87%
-0.0283
After Hours:
.95
-0.0094
-0.98%
Marker Therapeutics Inc stock is traded at $0.9594, with a volume of 173.34K.
It is down -2.87% in the last 24 hours and up +0.47% over the past month.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
See More
Previous Close:
$0.9877
Open:
$0.985
24h Volume:
173.34K
Relative Volume:
0.18
Market Cap:
$12.41M
Revenue:
-
Net Income/Loss:
$-9.70M
P/E Ratio:
-0.8722
EPS:
-1.1
Net Cash Flow:
$-8.57M
1W Performance:
-6.40%
1M Performance:
+0.47%
6M Performance:
-23.25%
1Y Performance:
-73.79%
1-Day Range:
$0.95
$0.985
1-Week Range:
$0.95
$1.04
52-Week Range:
$0.8099
$5.95
Marker Therapeutics Inc Stock (MRKR) Company Profile
Name
Marker Therapeutics Inc
Sector
Industry
Phone
(713) 400-6400
Address
2450 HOLCOMBE BLVD, HOUSTON, TX
Compare MRKR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRKR
Marker Therapeutics Inc
|
0.9594 | 12.78M | 0 | -9.70M | -8.57M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Marker Therapeutics Inc Stock (MRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-05-25 | Initiated | Canaccord Genuity | Buy |
| Mar-25-21 | Initiated | Piper Sandler | Overweight |
| Mar-19-21 | Initiated | Cantor Fitzgerald | Overweight |
| May-12-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-30-19 | Initiated | ROTH Capital | Buy |
| Mar-01-19 | Initiated | Janney | Buy |
| Dec-03-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
View All
Marker Therapeutics Inc Stock (MRKR) Latest News
Reversal indicators forming on Marker Therapeutics Inc. stockCEO Change & Long-Term Capital Growth Strategies - newser.com
Marker Therapeutics (NASDAQ: MRKR) to present MT-601 data at ASH; 66% ORR in NHL no ICANS - Stock Titan
Is Marker Therapeutics Inc. stock a buy on dipsJuly 2025 Sentiment & Expert Curated Trade Ideas - newser.com
Using Python tools to backtest Marker Therapeutics Inc. strategiesJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - newser.com
Published on: 2025-11-03 00:22:23 - newser.com
How forex fluctuations impact Marker Therapeutics Inc. (GX1) stockTrend Reversal & Free Safe Capital Growth Stock Tips - newser.com
Technical signs of recovery in Marker Therapeutics Inc.July 2025 Movers & Breakout Confirmation Trade Signals - newser.com
Tools to assess Marker Therapeutics Inc.’s risk profilePortfolio Return Report & Low Volatility Stock Recommendations - newser.com
Visual analytics tools that track Marker Therapeutics Inc. performanceDay Trade & Weekly Market Pulse Updates - newser.com
What makes Marker Therapeutics Inc. (GX1) stock appealing to growth investorsTreasury Yields & Long-Term Growth Plans - newser.com
Published on: 2025-11-02 15:53:33 - earlytimes.in
Does Marker Therapeutics Inc. fit your quant trading model2025 Top Decliners & Weekly Return Optimization Plans - newser.com
Is Marker Therapeutics Inc. reversing from oversold territoryWeekly Trend Report & Daily Profit Focused Stock Screening - newser.com
Is Marker Therapeutics Inc. (GX1) stock prepared for digital transitionWeekly Investment Report & Community Verified Swing Trade Signals - newser.com
Published on: 2025-10-29 03:27:17 - newser.com
Why Marker Therapeutics Inc. stock could outperform in 2025Exit Point & Real-Time Stock Movement Alerts - fcp.pa.gov.br
What catalysts could drive Marker Therapeutics Inc. stock higherQuarterly Market Summary & Daily Stock Trend Reports - fcp.pa.gov.br
Why Marker Therapeutics Inc. stock is trending among retail traders2025 Earnings Surprises & Risk Adjusted Swing Trade Ideas - fcp.pa.gov.br
Does Marker Therapeutics Inc. show high probability of reboundWeekly Loss Report & Free Growth Oriented Trading Recommendations - newser.com
Will Marker Therapeutics Inc. stock see insider buying2025 Bull vs Bear & Free Community Consensus Stock Picks - fcp.pa.gov.br
Is Marker Therapeutics Inc. stock near bottom after declineJuly 2025 Rallies & Low Risk Growth Stock Ideas - fcp.pa.gov.br
Marker Therapeutics Inc Stock (MRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):